@article{f369a075216b4f249af276e1c9cda076,
title = "Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention",
keywords = "Antiplatelet therapy, Complex PCI, Dual antithrombotic therapy, Dual pathway inhibition, Left main disease",
author = "Alessandro Spirito and Peter Cangialosi and Davide Cao and Johny Nicolas and Roxana Mehran",
note = "Funding Information: Dr. R. Mehran reports institutional research grants from Abbott , Abiomed , Applied Therapeutics , ARENA , AstraZeneca , Bayer , Biosensors, Singapore , Boston Scientific , Bristol-Myers Squibb , CardiaWave , CellAegis , CERC, France , Chiesi , Concept Medical , CSL Behring , DSI , Insel Gruppe AG , Medtronic , Novartis Pharmaceuticals , OrbusNeich , Philips , Transverse Medical , Zoll; personal fees from ACC, Boston Scientific, California Institute for Regenerative Medicine (CIRM), Cine-Med Research, Janssen, WebMD, SCAI; consulting fees paid to the institution from Abbott, Abiomed, AM-Pharma, Alleviant Medical, Bayer, Beth Israel Deaconess, CardiaWave, CeloNova, Chiesi, Concept Medical, DSI, Duke University, Idorsia Pharmaceuticals, Medtronic, Novartis, Philips; Equity less than 1% in Applied Therapeutics, Elixir Medical, STEL, CONTROLRAD (spouse); Scientific Advisory Board for AMA, Biosensors (spouse). Dr A. Spirito received a research grant from the Swiss National Science Foundation (SNSF), Switzerland . The other authors have nothing to disclose.",
year = "2022",
month = oct,
doi = "10.1016/j.iccl.2022.02.003",
language = "English",
volume = "11",
pages = "419--428",
journal = "Interventional Cardiology Clinics",
issn = "2211-7458",
publisher = "Elsevier Inc.",
number = "4",
}